Man Group PLC Travere Therapeutics, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 98,662 shares of TVTX stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98,662
Previous 117,601
16.1%
Holding current value
$1.83 Million
Previous $906,000
10.49%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TVTX
# of Institutions
185Shares Held
90.4MCall Options Held
305KPut Options Held
184K-
Armistice Capital, LLC New York, NY7.65MShares$142 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$128 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$86.9 Million2.23% of portfolio
-
Macquarie Group LTD Australia, C34.27MShares$79.3 Million0.07% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.19B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...